A sign stands outside a Abbvie facility in Cambridge, Massachusetts, May 20, 2021.
Brian Snyder | Reuters
Abbvie (ABBV) is a leading biopharmaceutical firm that's transformed itself from a mostly one-drug company to a diversified business after the 2020 acquisition of Allergan.